임플로이어스 홀딩스(EIG) 2026년 3분기 실적 발표: 보험료 감소 속에 수익성 개선
임플로이어스 홀딩스는 2026년 3분기 희석주당순이익 0.64달러를 기록해 전년 동기 순손실에서 흑자 전환했다. 손해율 및 손해조사비 비율은 71.2%로 개선되었으며, GAAP 합산비율은 108.4%로 하락했다. 원수보험료는 연성 시장 속 의도적인 요율 인상 및 인수 조치로 18% 감소한 1억 5,110만 달러를 기록했다. 순투자수익은 사모펀드 분배금을 포함해 23.8% 증가한 3,230만 달러로 집계됐다. 경영진은 2025년 말 시작된 재인수 절차가 4분기 중 완료되어 보험료가 안정될 것으로 예상하고 있으나, 산재보험 손해비용 하락으로 매출 성장은 여전히 어려울 것으로 전망했다.
핵심 요약
- 임플로이어스 홀딩스(Employers Holdings, Inc., NYSE: EIG)는 2026년 3분기 희석주당순이익 0.64달러를 기록해, 주당 0.36달러의 순손실을 낸 2025년 3분기 대비 흑자 전환했다고 발표했다. 조정 희석주당순이익은 0.71달러로, 전년 동기의 조정 희석주당순손실 1.10달러 대비 개선되었다.
- 손해율 및 손해조사비(LAE) 비율은 전년 동기에 3,800만 달러 규모의 준비금 증액이 포함되었던 영향으로 97.1%에서 71.2%로 개선되었다. 회사는 2026년 동안 임의 보험(voluntary business) 부문에서 전년도 준비금 변동(prior-year development)이 발생하지 않았다고 밝혔다.
- GAAP 합산비율은 129.7%에서 108.4%로 하락했다. 경영진은 이러한 개선이 상당한 수준이라고 평가하면서도, 인수 수익성을 과거 수준으로 회복하는 데 계속 집중하고 있다고 밝혔다.
- 원수보험료(Gross premiums written)는 1억 5,110만 달러로 18% 감소했으며, 경과보험료(Net premiums earned)는 1억 6,020만 달러로 17% 감소했다. 이러한 감소는 장기화된 연성 시장(soft market) 속에서 의도적인 요율 인상 및 인수 조정 조치를 반영한 결과다.
- 순투자수익은 사모펀드(PE) 투자 수익 560만 달러를 포함해 3,230만 달러로 23.8% 증가했다. 해당 분배금을 제외한 투자수익은 약 2,670만 달러로 6% 증가했다.
- 경영진은 표적 재인수(re-underwriting) 프로그램이 2026년 4분기 동안 전체 포트폴리오에 반영 완료될 것으로 예상하고 있으며, 이후 보험료 수입이 어느 정도 안정될 것으로 전망하고 있다.
주요 재무 데이터
| 지표 | 2026년 3분기 | 2025년 3분기 | 변동 / 비고 |
|---|---|---|---|
| 원수보험료 | 1억 5,110만 달러 | 1억 8,390만 달러 | 18% 감소 |
| 경과보험료 | 1억 6,020만 달러 | — | 전년 동기 대비 17% 감소 |
| 희석주당순이익 | $0.64 | $(0.36) | 전년 동기 대비 개선 |
| 조정 희석주당순이익 | $0.71 | $(1.10) | 전년 동기 대비 개선 |
| 조정 순이익 | 1,280만 달러 | $(2,550만) 달러 | 전년 동기는 조정 순손실 |
| 손해율 및 손해조사비율 | 71.2% | 97.1% | 전년 동기에는 3,800만 달러의 준비금 증액 포함 |
| LPT 제외 당해 사고연도 손해율 및 손해조사비율 | 72.0% | — | 임의 보험 부문 |
| GAAP 합산비율 | 108.4% | 129.7% | LPT 제외 시 109.2% |
| 사업비율 | 24.3% | 20.6% | 보험료 기반 감소로 인해 상승 |
| 수수료 비용 비율 | 12.9% | 12.0% | 신규 계약 수수료율 인상 및 전년도 조정 여파 |
| 순투자수익 | 3,230만 달러 | — | 23.8% 증가 |
| 주주 지분 | 7억 8,560만 달러 | — | 2026년 6월 30일 기준 8억 5,880만 달러에서 감소 |
| 주당 조정 장부가치 | $53.64 | — | 배당금 포함 전년 동기 대비 7.1%, 전분기 대비 1.3% 증가 |
연초 대비 누적 순이익은 5,080만 달러로, 2025년 첫 9개월간의 3,420만 달러와 비교된다. 조정 순이익은 740만 달러에서 3,590만 달러로 증가했다.
사업 및 영업 실적
유효 보험 계약 수는 약 12만 4,000건으로 8% 감소했다. 보험료 수입 감소폭에 비해 계약 수 감소폭이 적었던 것은 특정 업종 및 지역에서 철수하면서도 소상공인 고객 대부분을 유지했기 때문이다.
6월에 출시된 초과 산재보험(excess workers’ compensation) 상품은 실적 발표 시점까지 31건의 계정 및 650만 달러의 보험료를 유치했다. 임플로이어스 홀딩스는 또한 2027년 출시를 목표로 고액 자기부담금(large-deductible) 상품 개발에 착수했다.
기술 투자 및 AI 도입도 지속적으로 확대되었다. 기술팀은 2026년 3분기 동안 적용 가능한 업무 과제의 3분의 2에 AI를 활용했다. 새로운 AI 기반 보상 요약 애플리케이션이 회사의 진행 중인 전체 보상 건을 평가했으며, 경영진은 이를 통해 보상팀이 3년간 5만 시간 이상을 다른 업무로 전환 배분할 수 있을 것으로 기대하고 있다.
채권 포트폴리오의 장부 수익률은 전년 동기 대비 40bp 상승한 5%를 기록했다. 수정 듀레이션은 4.3이었으며, 평균 신용등급은 A+를 유지했다. 금리 상승으로 인해 만기매구증권의 시가가 하락하면서 기타포괄손실누계액이 6,170만 달러 증가한 7,400만 달러를 기록했다. 경영진은 이러한 시가 하락이 신용 등급 악화와는 무관하다고 밝혔다.
임플로이어스 홀딩스는 해당 분기 동안 자사주 매입 1,810만 달러, 정기 배당 630만 달러를 포함해 총 2,440만 달러를 주주에게 환원했다. 회사는 주당 평균 48.44달러에 37만 3,848주를 매입했으며, 2026년 자사주 매입 한도 중 9,490만 달러가 남아있다. 이사회는 또한 11월 12일 기준 주주를 대상으로 12월 3일에 지급될 2026년 4분기 주당 0.34달러의 배당금을 의결했다.
경영진 전망
경영진은 2025년 말에 시작된 표적 재인수 절차가 2026년 4분기 중 전체 포트폴리오에 적용될 것으로 예상한다. 대상 계약의 해지 또는 갱신 거절이 완료되면 매출(top-line)의 안정성이 향상될 것으로 기대하고 있으나, 산재보험 손해비용이 계속 하락하는 상황에서 매출 성장은 여전히 어렵다고 강조했다.
재투자 수익률 상승은 향후 실적을 뒷받침할 것으로 기대된다. 회사는 또한 고액 자기부담금 산재보험 상품의 2027년 출시를 목표로 하고 있다.
리스크 및 점검 항목
- GAAP 합산비율은 전년 동기 대비 대폭 개선되었음에도 108.4%로 100%를 상회했다.
- 소프트한 가격 환경에서 회사가 성장보다 수익성을 우선시함에 따라 보험료 규모 감소세가 지속되었다.
- 경영진은 보험사 간 점유율 경쟁으로 인해 신규 계약 수수료의 상승 압력이 지속되고 있다고 밝혔다. 임플로이어스 홀딩스는 인수 마진이 허용한다고 판단되는 경우에만 수수료를 인상하고 있다.
- 전국적인 청구 빈도는 캘리포니아 외 지역 주들에 힘입어 감소세를 이어갔다. 그러나 캘리포니아의 청구 빈도는 2025년까지의 누적 상해(cumulative trauma) 청구 영향으로 최근 사고연도에 증가했다.
- 경영진은 2026 사고연도에 대해 캘리포니아 외 지역에서 손해 심도 상승 압력의 초기 징후를 언급했으나, 이는 광범위한 트렌드라기보다는 소수의 대액 손실 때문이라고 설명했다.
- 금리 상승으로 인해 채권형 증권의 시가가 하락하고 보고된 장부가치에 부담을 주었으나, 경영진은 이러한 변동이 신용 등급 악화를 반영하는 것은 아니라고 밝혔다.
애널리스트 Q&A 주요 내용
재인수 및 보험료 안정화: 경영진은 조치가 광범위하게 적용되기보다는 특정 업종 및 지역에 집중되었다고 밝혔다. 이러한 절차는 2026년 4분기 말까지 포트폴리오 전반에 실질적으로 반영되어 이후 보험료 안정화를 어느 정도 뒷받침할 것으로 예상된다.
청구 빈도: 전국 포트폴리오 전반에서 청구 빈도가 계속 감소했으나 캘리포니아는 예외였다. 경영진은 캘리포니아의 청구 빈도 상승의 주요 원인으로 누적 상해(cumulative trauma)를 꼽았으며, 자기부담금 보유액(self-insured retentions)이 큰 대형 피보험자는 청구 빈도 변화에 덜 민감할 수 있으므로 신규 초과 산재보험 사업이 익스포저를 다변화할 것이라고 밝혔다.
급여 감사 및 계약 해지: 감사 충당금은 약 2,300만 달러 수준을 유지하며 2026년 3분기 동안 변동이 없었다. 회사는 약 230만 달러의 미준수 보험료(noncompliance premium)를 인식했다. 계약 해지는 전년 동기 대비 비슷했으나, 대리점들이 더 나은 가격이나 더 높은 수수료를 모색함에 따라 청약 신청 및 견적 건수는 증가했다.
의료 및 의약품 비용: 전반적인 손해 심도는 보합 또는 감소세를 보였다. 회사의 의약품 비용 지수는 팬데믹 이전 수준을 소폭 상회했으나, 경영진은 의료비 부담 능력 문제가 포트폴리오 내 청구 행태를 실질적으로 변화시키고 있다는 증거는 관찰되지 않았다고 밝혔다.
실적 발표 전화회의 전문
전체 실적 발표 컨퍼런스 콜 녹취록
경영진 발표
Operator
Good day, and thank you for standing by. Welcome to the Q3 2026 Employers Holdings, Inc. Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Jeff Lisenby, General Counsel for Employers Holdings. Please go ahead.
Jeffrey Lisenby
Thank you, Danny. Today's call is being recorded and webcast from the Investors section of our website, where a replay will be available following the call.
Statements made during this conference call that are not based on historical facts are considered forward-looking statements. These statements are made in reliance on the safe harbor provision of the Private Securities Litigation Reform Act of 1995. Although we believe the expectations expressed in our forward-looking statements are reasonable, risks and uncertainties could cause actual results to be materially different from our expectations, including the risks set forth in our filings with the Securities and Exchange Commission.
All remarks made during the call are current only at the time of the call and will not be updated to reflect subsequent developments. The company also uses its website as a means of disclosing material nonpublic information and for complying with disclosure obligations under SEC Regulation FD. Such disclosures will be included in the Investors section of our website. Accordingly, investors should monitor that section of our website in addition to following our press releases, SEC filings, public conference calls and webcast.
In our earnings press release and in our remarks or responses to questions, we may use non-GAAP financial measures. Reconciliations of these non-GAAP measures to our GAAP results are included in our financial supplement as an attachment to our earnings press release, our investor presentation and any other materials available in the Investors section of our website.
Now, I will turn the call over to Kathy Antonello, our Chief Executive Officer.
Katherine Antonello
Thank you, Jeff. Good morning, everyone, and welcome to our third quarter 2026 earnings call. Joining me today is Mike Pedraja, our Chief Financial Officer. As usual, I will begin with highlights of our third quarter results and then hand it over to Mike for more detail on our financials. Before we take your questions, I'll come back with some closing thoughts.
Our third quarter results reflect the progress we're making to restore our underwriting profitability to historical levels. We reported net income of $0.64 per diluted share compared to a net loss of $0.36 per diluted share in Q3 of 2025. Adjusted net income was $0.71 per diluted share compared to an adjusted net loss of $1.10 per diluted share. The improvement in earnings was driven primarily by the absence of the $38 million of reserve strengthening we recorded in the third quarter of 2025. Our loss and LAE ratio improved to 71.2% from 97.1%. We have not recognized any prior year development on our voluntary business this year, and our current accident year loss and LAE ratio, excluding the loss portfolio transfer, is 72%.
Our GAAP combined ratio improved to 108.4% from 129.7%. That is significant progress, but we are not satisfied with that level, and we'll continue to strive for underwriting improvement. The reduction in the loss and LAE ratio was slightly offset by the underwriting expense ratio, which was 24.3% compared to 20.6% a year ago and reflected the smaller premium base. Gross premiums written were $151.1 million, a decrease of 18% and net premiums earned were $160.2 million, a decrease of 17%. These decreases reflect the pricing and underwriting actions we've taken to prioritize profitability in the prolonged soft market. Policies in force declined 8% to about 124,000, a smaller decline than premium as we retained the majority of our small business customers while exiting selected classes of business.
Underwriting expenses decreased slightly, primarily because of lower policyholder dividends, lower bad debt expense and premium taxes and assessments. Our commission expense ratio was 12.9% compared to 12% a year ago. Our investment portfolio was a positive contributor with net investment income increasing to $32.3 million, supported by higher yields following our 2025 investment rebalancing and $5.6 million in returns from our private equity investments.
With the significant rise in U.S. interest rates, our portfolio is well positioned to take advantage of higher reinvestment rates, which should contribute to earnings over time. Higher rates also impacted our book value through unrealized market value declines in our fixed income portfolio. The decrease is not a reflection of credit quality. Book value per share, including the deferred gain, was $49.44, up 2.1% from a year ago, but down 5.3% from the end of the second quarter, with both rates including dividends. Adjusted book value per share, which excludes accumulated other comprehensive income, was $53.64, up 7.1% from a year ago and up 1.3% from last quarter, again, with both rates including dividends.
With that, Mike will provide a deeper dive into our third quarter financial results, and then I'll return with some closing remarks. Mike?
Michael Pedraja
Thank you, Kathy. Gross premiums written were $151.1 million compared to $183.9 million for the prior year quarter, a decrease of 18%, reflecting the deliberate pricing and underwriting actions we began in 2025. These actions contributed to declines in both new and renewal business premiums in the quarter. Our losses and LAE were $114 million, a decrease of 38.9%. The decrease was primarily due to the absence of last year's reserve strengthening Kathy mentioned. Our voluntary business, current accident year loss and LAE ratio, excluding the LPT, was 72%. Our reported loss and LAE ratio was 71.2% compared to 97.1% a year ago.
Commission expense was $20.6 million, a decrease of 10.4%, consistent with lower premiums. Our commission expense ratio was 12.9% compared to 12% a year ago. The increase in the ratio was due primarily to higher commission rates on new business writings in 2026, combined with a onetime adjustment that reduced the 2025 third quarter ratio. Underwriting expenses were $38.9 million, a decrease of 1.8%. Our underwriting expense ratio was 24.3% compared to 20.6% a year ago. Overall, our GAAP combined ratio was 108.4% or 109.2%, excluding the LPT, compared to 129.7% and 130.4% a year ago. Net investment income was $32.3 million, an increase of 23.8%. The increase was primarily the result from our private equity investments, which contributed $5.6 million of distributions this quarter, along with higher yields on fixed maturity securities resulting from our investment rebalancing activity in 2025.
Excluding the private equity distributions, net investment income was approximately $26.7 million, up 6% from last year. Our fixed income book yield was 5%, a 40 basis point increase from last year, while our modified duration was 4.3 and average credit quality remained strong at A+. Net realized and unrealized losses on investments were $3.2 million compared to gains of $21.2 million a year ago. The current period's result was driven by a reduction in the net asset value of our private equity investments related to distributions and by reduced common equity investment gains. Interest and financing expenses were $1.3 million versus $0.2 million a year ago. The increase relates to our $125 million of senior debt associated with the recapitalization plan we announced in the fourth quarter of 2025.
Federal and state income tax expense was $2.9 million, a 20% effective tax rate compared to a benefit of $2.9 million or a 25.9% effective benefit rate a year ago. Our adjusted net income, which excludes net realized and unrealized investment gains and losses, and the benefit of LPT deferred gain amortization was $12.8 million for the quarter compared to an adjusted net loss of $25.5 million last year. Year-to-date, net income was $50.8 million and adjusted net income was $35.9 million compared to $34.2 million and $7.4 million for the 9 months of last year.
Turning to the balance sheet. Stockholders' equity was $785.6 million at quarter end, down from $858.8 million at June 30. Accumulated other comprehensive loss increased by $61.7 million to $74 million due directly to higher interest rates, reducing the market value of our fixed maturity securities. And as Kathy mentioned, is not related to credit quality. These unrealized losses should reverse as bonds approach maturity or if interest rates decline. Adjusted shareholders' equity, which excludes accumulated other comprehensive income and adds back the deferred gain was $943.6 million. We returned $24.4 million to stockholders in the quarter through $18.1 million of share repurchases and $6.3 million of regular quarterly dividends. We repurchased 373,848 shares at an average price of $48.44 per share. That price represented an 8% discount to our beginning book value per share, including the deferred gain and a 9% discount to our beginning adjusted book value per share. We have $94.9 million of repurchase authorization remaining under the 2026 program.
With that, I'll turn the call back to Kathy.
Katherine Antonello
Thank you, Mike. Yesterday, our Board of Directors declared a fourth quarter 2026 dividend of $0.34 per share payable on December 3 to stockholders of record as of November 12. Looking ahead, expanding our workers' compensation product offering is driving additional profitable growth and deepening our relationships with distribution partners. Our excess workers' compensation product, which we launched in June, is off to a strong start with 31 accounts and $6.5 million in premium to date. The product feedback from the market on our value-added service offerings has been very positive. We've begun developing our large deductible product, which we are targeting to launch next year.
We continue to make progress with our technology investments and AI adoption is growing each quarter. AI agents are now writing, testing and documenting software at Employers with the technology team utilizing AI in 2/3 of eligible work tasks in the third quarter. The results are tangible. This month, our new AI-driven claims summary application went live after assessing our entire inventory of open claims. We expect this new tool will allow our claims team to redeploy more than 50,000 hours over 3 years, with the efficiency ultimately benefiting our insureds, their injured workers and the company. It is a very exciting time at Employers, and we are confident that these investments are leading to a stronger and more resilient company.
And with that, Daniel, we will now take questions.
Operator
[Operator Instructions] Our first question comes from Mark Hughes with Truist.
질의응답
Mark Hughes
Kathy, the re-underwriting process, I think you started it late in the year last year. When do you think you have -- will have largely completed that and maybe get on the -- more of a footing to hold the top line stable or perhaps grow maybe too tough to ask in this kind of market, but that re-underwriting process, how much more do you have?
Katherine Antonello
Yes. It's a great question, Mark, and you hit on something that is important, it is very tough to grow in a market where loss costs continue to decline. But I will say, when you speak about the re-underwriting effort, it was very surgical. It was in specific classes and jurisdictions. And as you mentioned, we started at the end of last year, and we expect that to roll through the entire book within the fourth quarter of this year. So beyond that, we would expect that premiums will stabilize to some extent because we will be -- all those policies will have nonrenewed or canceled, and we will go back to some stability in our top line.
Mark Hughes
Appreciate that. The question of frequency has come up in a couple of different ways. I was just sort of curious your thoughts on frequency in your book. And then if you hear others like, say, Hartford saying that they're seeing a little bit more of an uptick in frequency, does that make sense in this kind of market?
Katherine Antonello
Yes. I've seen the transcripts where more and more carriers are calling out increases in frequency. I'll talk about our book to begin with. What we're seeing is frequency continuing to decline countrywide. But the devil's in the details, right? When you start to drill down, you might see things differently in different jurisdictions. The decline that we're seeing country-wide is being driven by claims outside of California. That's not new for us. It's something that we've talked about in earnings calls over the past year, 1.5 years. The frequency decreases countrywide are consistent with what you're seeing during the State of the Line and so forth with the long-term industry trends.
California frequency, as I said before, has increased in the latest accident years, and that's consistent with what the WCIRB is seeing and one of the reasons why they are filing for increases. For us, up through 2025, that was driven by cumulative trauma claim frequency. Excluding the CT claims, up through 2025, California claim frequency continued to trend downward. So we're keeping an eye on it. It can be a little bit lumpy from quarter-to-quarter. But overall, country-wide, I would just say that we're seeing decreases. I haven't seen much discussion in the earnings call transcripts from others in terms of what jurisdictions are driving that. But for us, I can tell you where we see the increases in California.
Mark Hughes
Yes. Interesting. How about the audits in the quarter? Anything it tells you about the payrolls and then cancellations? Is there any kind of uptick in cancellations maybe related to more aggressive competition or shopping?
Katherine Antonello
Yes. I mean in terms of audit, year-over-year, the audit pickup combined with our change in accrual wasn't -- they were very close, so we're not seeing a huge change there. Our audit accrual currently stands at about $23 million, and we didn't make any change to that in the third quarter of '26. We're seeing a little bit of an uptick in noncompliance premium. We recognized about $2.3 million of that this quarter. So not seeing a ton of change in terms of audit. You also asked about cancellations. I would say our cancellations are relatively flat year-over-year also. We -- where we're seeing big increases are in our submissions and our quotes which would, to me, say that more agents are shopping business to try to get a better price or a higher commission. So that could be something that's going on that policyholders are canceling policies looking for better prices.
Mark Hughes
Yes. I'll ask one final question, if I might. The -- are you seeing much upward pressure on commissions? I think your reported commissions are -- looks like they're holding reasonably stable. I think maybe there's some nonrecurring stuff in the year ago quarter on commissions, if I understand it properly. But are you seeing brokers pushing and maybe that is impacting your win rate or hit rate on those quotes?
Katherine Antonello
I would say yes to all of that. In regard to our commission rate, you're absolutely correct. There was an adjustment that occurred in the third quarter of 2025 that -- so that 12% from a year ago may have been slightly lower than we would normally see. But in terms of the competitive environment, we are seeing continued pressure on commissions for new business. So I think that just comes with the territory of the softer market and carriers competing to keep their market share. We are not chasing that everywhere. We're looking for pockets where we can increase commission, where we feel like there's room in the margin to do so. But there is a lot of upward pressure on commissions right now.
Operator
[Operator Instructions] Our next question comes from Karol Chmiel with Citizens.
Karol Chmiel
Kathy, just to go back to what Mark was inquiring regarding the audit. I know there wasn't much change. But in the bigger picture, with the whole higher cost of living and now various states and counties and cities pushing for higher minimum wage, are you having any conversations with your clients as to audit issues maybe coming up in the future where companies are going to be doing more with less workers?
Katherine Antonello
Yes, it's a good question. It's something we keep an eye on in terms of just macroeconomic, the picture there. I can't say that we've had -- given our policyholder base and just the small accounts that we typically write, I don't know that we've had any specific conversations, but we do track the economic behavior of what that might impact our book of business. Not seeing anything right now that would change what I feel like is our audit pickup in the future. I will say it's nothing like what we were seeing, say, coming out of the pandemic when payrolls were just increasing at such a dramatic rate. Things are fairly stable now. And we're -- we see from month to month that: one month, we might have a pickup; the next month, we might have a return in total, but not a lot of movement there.
Operator
Our next question comes from Alex Scott with Barclays. This is Justin on for Alex.
Unknown Analyst
I wanted to revisit the topic of frequency. I understand the frequency outside of California continues to be trending lower for your book of business. I was just wondering if there are any particular, say, industries or claims types or even worker populations where you may be seeing some frequency pressures emerge or maybe the rate of frequency declines are not as pronounced as it has been before?
Katherine Antonello
Yes, it's a great question. I mean, for us, and I'm talking about our guaranteed cost workers' compensation book, the area where we're seeing the most elevated frequency and then over the last 2 to 3 years, the largest increase in frequency has been California cumulative trauma. So, I will say one of the things that -- one of our strategic moves to, sort of, give us more optionality was to move into the excess workers' compensation space, which will diversify our book of business and allow us to write larger insureds with self-insured retentions that might not be impacted by changes in frequency to the same extent that you would see in a small business guaranteed cost book.
So, for us, that move was intentional. So, for example, if I stick with California and CT, we just got approved to write excess workers' comp in California. We would not expect that future book to be impacted by frequency increases as much as it has impacted the guaranteed cost book. In terms of industries, I have not seen that there are increases in frequency. I've seen no research, and I haven't seen anything in our book that is showing anything in terms of the frequency is more -- the increase in frequency is more prevalent or the lack of a decrease is more prevalent in one industry versus another.
Unknown Analyst
Understood. And maybe a quick follow-up on a similar point. I think we've been hearing some discussion around sort of the rising cost of health care costs and sort of the affordability potentially affecting workers' claims comp behavior. So, sort of, like historically, maybe some claims that have been addressed in health care is now spilling over into workers' comp claims instead. I was wondering if this was something that you are seeing in your own book of business or if there's any sort of observations that you're seeing industry-wide that talks to this sort of observation?
Katherine Antonello
Yes. I mean I'll start with our book. When we look at our book overall, severity is very steady or lower. And we have early indications with accident year 2026 in states outside of California that we might have some pressure on severity, but that's almost -- that's entirely driven by a few large losses. So, I wouldn't call it a widespread severity trend. We have, for the last 5 or 6 years, developed our own pharmaceutical index that we continue to look at. And those costs are up slightly relative to what we were seeing pre-pandemic levels. We had a recent uptick that recovered most of the post-pandemic decline, but it's really pretty moderate. So, I have also heard what you've heard, sort of, out on the street, but we're not seeing anything in our book right now that would suggest it's impacting us.
Operator
I'm showing no further questions at this time. I would now like to turn it back to Kathy Antonello for closing remarks.
Katherine Antonello
Okay. Thank you, Daniel, and thank you all for joining us this morning, and we look forward to speaking with you all again in February.
Operator
This concludes today's conference call. Thank you for participating. You may now disconnect.
이 문서에는 사람이 검토한 AI 생성 콘텐츠 또는 AI 번역 콘텐츠가 포함될 수 있습니다. 이는 참고용 및 전반적인 정보를 제공용으로만 제공되며 투자 조언에 해당하지 않습니다.
추천 기사








코멘트 (0)
$ 버튼을 클릭하고, 종목 코드를 입력한 후 주식, ETF 또는 기타 티커를 연결합니다.